Clinical Trial

Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety, tolerability, and preliminary efficacy of rectus sheath injection of hepatocyte-like cells in the treatment and prevention of small-for-size syndrome, with the ultimate goal of improving patient survival.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-14
Trial Details
NCT Number NCT07276568
Lead Sponsor Zhi-Jun Zhu
Conditions Small-for-size Syndrome
Enrollment 12 participants
Start Date 2025-12-17
Primary Completion 2028-12-01 (estimated)
Study Completion 2029-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15